|* Explore the possibility of collaborative projects
* Discuss opportunities of industrial experience for early stage researchers.
* Challenge existing theories and approaches to neurodegeneration
) is a privately held company taking a new approach to neurodegenerative disorders such as Alzheimer's Disease
Building on 40 years of original research initially at Oxford University, and now based at the Culham Science Centre, we research a novel signaling molecule (a peptide 'T14') significantly elevated in Alzheimer's brains and driving the cycle of brain cell death in selectively vulnerable cells.
For further details of the event, please click
REGISTRATION: We would be grateful if you could indicate your interest by February 20th.
All queries and RSVP to Julie Peachey